04 Oct 2024
// PRESS RELEASE
17 Jun 2024
// PRESS RELEASE
13 Jun 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Reset all filters
01 1CAPTOPRIL
02 6MORPHINE SULFATE
Reset all filters
01 6CAPSULE (EXTENDED RELEASE)
02 1SOLUTION
Reset all filters
01 1100MG
02 110MG
03 115MG
04 1200MG
05 125MG/5ML
06 130MG
07 160MG
Reset all filters
01 6M-ESLON
02 1NOYADA
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 15MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2177749
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 200MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2177757
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 30MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019949
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 100MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019965
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 60MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019957
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 10MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019930
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 25MG/5ML
Packaging :
Brand Name : NOYADA
Approval Date :
Application Number : 2543915
Regulatory Info :
Registration Country : Canada